At this time, testing can only be directed to the Roche 6800/8800 platform. If a common code is used, the results are reported with a comment stating the platform and reagents used.
Yes. Testing is by Bio-Rad Laboratories for SARS-CoV-2 on the QX200 and QXDx Droplet Digital PCR (ddPCR) Systems. This is a quantitative test.
The Ortho Clinical Diagnostics assay is an IgG directed toward the SARS-CoV-2-spike protein.
No. However, a signal-to-cutoff (S/Co) ratio can be provided as a semi-quantitative value for an additional fee.
BioPharma Diagnostics has a qualitative serology antibody test that is total antibody and directed toward the SARS-CoV-2 nucleocapsid protein. This test is performed using the Roche Elecsys platform.
For information about COVID-19 testing, see COVID-19 BioPharma Resources.
For test-specific information, search for a test in the test catalog.
This question is handled on a case-by-case basis with the laboratory where testing is performed.